Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.

MLA

Van den Berghe, G., et al. “Thyrotropin-Releasing Hormone in Critical Illness: From a Dopamine-Dependent Test to a Strategy for Increasing Low Serum Triiodothyronine, Prolactin, and Growth Hormone Concentrations.” Critical Care Medicine, vol. 24, no. 4, Apr. 1996, pp. 590–95. EBSCOhost, https://doi.org/10.1097/00003246-199604000-00007.

APA

Van den Berghe, G., de Zegher, F., Vlasselaers, D., Schetz, M., Verwaest, C., Ferdinande, P., & Lauwers, P. (1996). Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Critical Care Medicine, 24(4), 590–595. https://doi.org/10.1097/00003246-199604000-00007

Chicago

Van den Berghe, G, F de Zegher, D Vlasselaers, M Schetz, C Verwaest, P Ferdinande, and P Lauwers. 1996. “Thyrotropin-Releasing Hormone in Critical Illness: From a Dopamine-Dependent Test to a Strategy for Increasing Low Serum Triiodothyronine, Prolactin, and Growth Hormone Concentrations.” Critical Care Medicine 24 (4): 590–95. doi:10.1097/00003246-199604000-00007.